Feedback PLC Papworth NHS Hosp - contract renewal with Bleepa (5474N)
21 Mai 2020 - 8:00AM
UK Regulatory
TIDMFDBK
RNS Number : 5474N
Feedback PLC
21 May 2020
The information contained within this announcement is deemed by
the Company to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 ("MAR").
Feedback plc
Royal Papworth Hospital NHS Foundation Trust renews contract
with Feedback and adopts Bleepa (R)
-- Contract renewal incorporates use of Bleepa(R) , the medical
grade imaging-based communications platform
-- Second NHS Trust to adopt Bleepa(R)
London, 21 May 2020: Feedback plc (AIM: FDBK, "Feedback" or the
"Company"), the specialist medical imaging technology company,
today announces Royal Papworth Hospital NHS Foundation Trust
("Trust") has renewed its contract for clinical PACS (picture
archiving and communication system) services with Feedback Medical
Ltd, a wholly owned subsidiary of the Company. The renewal will
incorporate an upgrade to service, providing the Trust access to
Bleepa (R) , Feedback's flagship imaging-based communication
platform.
The contract, set for a term of 14 months, rel ates to
Feedback's Cadran PACS which has provided core medical imaging
services to the Trust since 2001. The contract includes the use of
Bleepa (R) as an upgrade to Cadran Web Viewer and will see Bleepa
(R) made available to all clinicians at the Trust.
Royal Papworth Hospital is the UK's leading heart and lung
hospital, treating more than 100,000 patients each year. Since
carrying out the UK's first successful heart transplant in 1979,
the hospital now performs more heart, heart-lung and lung
transplants each year than any other UK centre. In addition to
transplantation, Royal Papworth Hospital has the UK's largest
Respiratory Support and is one of five UK centres providing Extra
Corporeal Membrane Oxygenation (ECMO) to patients experiencing
severe respiratory failure.
For Feedback, the contract marks the second NHS site to adopt
Bleepa (R) as a core imaging tool and is further recognition of the
potential that Bleepa (R) has to enhance clinical care delivery.
The first site was the Pennine Acute NHS Hospitals Trust which is
using Bleepa (R) to support frontline staff to manage Covid-19
patients.
Tom Oakley, CEO of Feedback plc, said:
"Papworth has been a longstanding customer of Feedback and we
are delighted that they recognise the value of Bleepa (R) as part
of this renewal. Enabling critical review at the push of a button,
Bleepa (R) has the functionality to bring significant efficiencies
and deliver real time-saving potential for its clinicians. The
launch of Bleepa at Papworth is further evidence of the changing
needs of frontline clinicians around their interaction with medical
imaging and with colleagues, something that we are uniquely
positioned to enable. We will now look to continue the spread of
Bleepa to other opportunities across the healthcare setting."
Bleepa(R) provides instant and remote access to clinical grade
medical images through a zero footprint application. The majority
of patient cases require medical imaging which can be seamlessly
shared to the entire clinical team through Bleepa (R) . Cases can
be discussed through its secure instant messaging and image
annotation, allowing comments and treatment decisions to be
communicated instantly between team members. Bleepa (R) can be
accessed from any internet connected device including phones,
tablets, laptops and desktops; clinicians can use their own devices
and therefore no additional hardware is required.
-Ends-
Enquiries:
Feedback plc +44 (0)1954 718072
Tom Oakley, CEO IR@fbk.com
Lindsay Melvin, CFO
Allenby Capital Limited (Nominated Adviser)
David Worlidge / Asha Chotai +44 (0)20 3328 5656
Peterhouse Capital Limited (Joint Broker)
Lucy Williams / Duncan Vasey +44 (0)20 7469 0936
Stanford Capital Partners Limited (Joint
Broker)
Patrick Claridge / John Howes +44 20 3815 8880
Instinctif Partners +44 (0)20 7457 2020
Melanie Toyne-Sewell / Phillip Marriage +44 7890 022 814
feedbackplc@instinctif.com
Notes to editors
About Feedback plc - www.fbk.com
Feedback plc (AIM: FDBK) is a specialist medical imaging
technology company providing innovative software and systems,
through its fully-owned trading subsidiary, Feedback Medical
Limited. Its products advance the work of radiologists, clinicians
and medical researchers by improving workflows and giving unique
insights into diseases, particularly cancer.
Feedback has launched Bleepa (R) , a new secure, encrypted
medical communication app for clinicians accessible through
smartphones, tablets and desktops that facilitates rapid clinical
messaging and review of medical grade imaging for all members of a
clinical team, directly from a hospital Picture Archiving and
Communications System (PACS). For more information on Bleepa , see
www.bleepa.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
CNTURRWRRWUVUAR
(END) Dow Jones Newswires
May 21, 2020 02:00 ET (06:00 GMT)
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024